Opendata, web and dolomites

GNU200

Innovative Solution in Microbiome Modulation to Benefit Infant Healthy growth

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GNU200 project word cloud

Explore the words cloud of the GNU200 project. It provides you a very rough idea of what is the project "GNU200" about.

malocclusion    molecules    infant    industry    indicates    efficacy    milk    formulae    infections    prebiotics    fundamental    200    closer    inconvenience    market    immune    breastfeeding    start    microbiota    ahead    alternatives    child    healthy    oligosaccharides    human    meat    campaigns    reinforce    similarly    infants    hmos    natural    composition    fos    abundant    prevents    serve    breastfeed    mimicking    diabetes    breast    business    parents    compensate    female    obesity    gastrointestinal    substitutes    home    alternative    treatment    naturally    proven    employed    protect    concentration    function    nature    despite    mix    declining    restores    fledgling    gnubiotics    diversity    protects    antibiotics    found    population    brain    replicate    mimics    benefits    probability    lack    poor    babies    prebiotic    onset    scientific    feed    thought    gnu    opportunity    hence    shape    substantially    choose    minimal    gos    rates    adding    diseases    components    reduces    birth    though    diet    explained    intelligence    overweight   

Project "GNU200" data sheet

The following table provides information about the project.

Coordinator
GNUBIOTICS SCIENCES SARL 

Organization address
address: ROUTE DE LA CORNICHE 4
city: EPALINGES
postcode: 1066
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website http://www.gnubiotics.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.2.4. (Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy)
2. H2020-EU.3.2.1. (Sustainable agriculture and forestry)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.2.2. (Sustainable and competitive agri-food sector for a safe and healthy diet)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-01-01   to  2018-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GNUBIOTICS SCIENCES SARL CH (EPALINGES) coordinator 50˙000.00

Map

 Project objective

Despite declining birth rates and the increasing number of campaigns to promote and support breastfeeding, the market for infant milk substitutes is growing. This is explained by the increasing employed female population, as well as inconvenience to breastfeed out of home. Scientific evidence indicates that breastfeeding protects against child infections and malocclusion, increases intelligence, and reduces overweight and diabetes’ probability. As an alternative to breastfeeding, parents choose to feed their babies with infant milk formulae that cannot replicate the effects and benefits of breast milk because fundamental components such as prebiotic human milk oligosaccharides (HMOs) are not included. To compensate for this lack of HMOs, oligosaccharides such as GOS and FOS are included, even though they are poor mimics of HMOs with minimal evidence of efficacy. HMOs, the third most abundant component in breast milk, are molecules naturally tailored to the need of an infant which serve as prebiotics that help shape microbiota composition, protect infants from diseases, foster healthy gastrointestinal systems, reinforce fledgling immune function, and promote early brain development. Adding HMOs in formulae will substantially improve child benefits, mimicking breast milk composition (bringing formulae closer to nature).

We, GNUbiotics, are a start-up that has developed GNU 200 thought a process based on a by-product from the meat industry. This natural prebiotic composed of a mix with high diversity and concentration of oligosaccharides with proven efficacy. Our product protects against infections, restores the microbiota diversity after antibiotics treatment and prevents the onset of diet induced obesity similarly to HMOs found in breast milk. Hence, it represents a great business opportunity several steps ahead than alternatives.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GNU200" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GNU200" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.2.4.;H2020-EU.3.2.1.;H2020-EU.2.3.1.;H2020-EU.3.2.2.)

TEST4ALL (2018)

ANTIBIOTICS CONTROL FOR ALL

Read More  

Stoock (2018)

An Innovative Integrated Field Sensor system providing a precise farming tool to reduce productioncosts and water wastage.

Read More  

IMBIO (2018)

Innovative Manure Biofertilizers

Read More